Noom Med GLP-1 Review 2026: The Best Coaching — But Read the Pricing Carefully

Noom has been in the weight loss space since 2008 — long before GLP-1 medications were household names. Its core thesis, built on 15 years of psychology research, is that sustainable weight loss requires changing behavior, not just restricting calories. That thesis has not changed with Noom Med. What has changed is that Noom now combines that behavioral foundation with access to the most powerful prescription weight loss medications ever developed.

The result is the most coaching-intensive GLP-1 program available from any major telehealth platform. It is also the most complex to navigate from a pricing standpoint — with five distinct program tiers, a confusing split between compounded and brand-name offerings, and advertised prices that do not always reflect what most patients will actually pay.

This review breaks down every tier, explains who each one is right for, and gives an honest assessment of where Noom earns its premium and where it does not.

Understanding Noom's Five-Tier Structure

Noom Med's pricing is more complex than any other major GLP-1 telehealth platform. Before evaluating whether Noom is right for you, you need to understand which plan you are actually comparing to alternatives.

Important context for this site: WeightRx Guide covers FDA-approved providers and brand-name medications. The tiers below that involve compounded medications are noted as such — compounded GLP-1s are not FDA-approved and carry the same caveats we apply across our reviews. For patients specifically seeking FDA-approved brand-name medications, the Telehealth Plan and the brand-name insurance track are the relevant options.

Tier 1: Telehealth for Branded Medications — $69/month

This is Noom's most underrated plan and the one most aligned with our editorial focus. For $69/month, you get:

• Clinical evaluation by a licensed Noom Med provider
• Prescription for a brand-name FDA-approved GLP-1 (Wegovy, Zepbound, Ozempic, Mounjaro) if appropriate
• Access to the full Noom behavioral app — daily CBT lessons, food tracking, community
• Noom GLP-1 Companion support tools
• Unlimited messaging with a dedicated care team
• Insurance benefit navigation support

The medication is filled at your preferred pharmacy and billed to your insurance or paid at NovoCare/LillyDirect cash-pay rates. Noom provides insurance support but does not have a dedicated prior authorization concierge team comparable to Ro's.

Who this is right for: Insured patients whose plans cover brand-name GLP-1s and who want Noom's behavioral coaching at the lowest possible add-on cost. At $69/month for the platform plus $0–$25/month for medication with a Novo savings card, the total cost can be under $100/month — an exceptional value.

Tier 2: Noom Microdose GLP-1Rx — $99/month

The Microdose program uses compounded semaglutide capped at a maximum 0.25–0.6 mg dose — significantly lower than the standard therapeutic range for weight loss (which goes up to 2.4 mg). It is designed for patients who want to try GLP-1 treatment at lower doses to minimize side effects or gauge their tolerance before committing to a full-dose program.

This is one of the most distinctive offerings in the telehealth space. No other major platform offers a dedicated, structured low-dose program as a product category.

Important note: This program uses compounded semaglutide, not FDA-approved Wegovy. The medication cost is bundled into the $99/month price, making it all-inclusive — a genuine simplicity advantage over platforms that bill medication separately.

Tier 3: Noom Proactive Health Microdose — $149/month

An enhanced version of the Microdose program that adds personalized biomarker monitoring and feedback alongside the low-dose compounded semaglutide. Updated pricing effective March 31, 2026.

Tier 4: Full-Dose GLP-1Rx (compounded) — $279/month

The standard compounded semaglutide program, all-inclusive at $279/month (first month $129 for new patients). Includes full titration up to therapeutic dosing, coaching, clinical support, and medication shipping. Uses compounded semaglutide from FDA-regulated 503B pharmacies.

Tier 5: Weight-Loss Pill Plan — $99/month (new for 2026)

The newest addition: a metformin-based program combined with Noom's full behavioral platform. Not a GLP-1 medication — metformin is an older diabetes drug with modest weight loss evidence used off-label. Relevant for patients who are not candidates for GLP-1 medications or want a bridge option.

The Coaching Program: Why It's Genuinely Different

This is where Noom's real differentiation lives, and it deserves detailed attention rather than a bullet point summary.

The behavioral foundation

Noom's coaching program was built on cognitive behavioral therapy (CBT) principles before GLP-1 medications existed. The core insight — that most weight regain happens because behavioral drivers of eating are never addressed — is well-supported by research. GLP-1 medications suppress appetite; they do not teach you why you eat when you are not hungry, how to recognize emotional eating patterns, or how to rebuild your relationship with food after years of restriction and regain cycles.

Noom's program does. The daily lesson curriculum covers:

• Cognitive restructuring of food-related thought patterns
• Emotional eating identification and intervention strategies
• Habit loop analysis (trigger, routine, reward)
• Sleep, stress, and movement as metabolic levers
• Portion calibration and hunger signal recognition
• Long-term maintenance planning

Each lesson takes approximately 10 minutes. The curriculum is delivered daily throughout your treatment, not front-loaded into an onboarding session.

The human coach

Every Noom Med patient receives a dedicated health coach — a real person, not an AI. Coaches check in weekly, review progress data from the app, and provide personalized guidance. This is meaningfully different from the "unlimited messaging" that most platforms offer, where you initiate contact with an unnamed care team member. The Noom coach relationship is ongoing, consistent, and two-way.

The 48% weight loss claim

Noom's published claim is that users who combine GLP-1 medications with their behavioral coaching lose 48% more weight in six months than those taking GLP-1 medications without the coaching program. This is based on retrospective analysis of self-reported data from active versus passive Noom users who were offered the program when being prescribed a GLP-1.

The study design has limitations — it is not a randomized controlled trial, and self-reported data has inherent bias. But the directional finding is consistent with clinical research showing that behavioral interventions meaningfully amplify GLP-1 outcomes, and that without behavioral support, weight regain after GLP-1 discontinuation is accelerated.

AI nutrition tools and community

New for 2026, Noom Med includes Welli — an AI-powered nutrition planning tool that personalizes meal suggestions based on your food preferences, cultural context, and GLP-1 side effect profile. The Noom community (branded "Noomers") provides peer support that most telehealth platforms entirely lack.

Noom also introduced Muscle Defense™ — a fitness tracking tool specifically designed to help patients on GLP-1 medications preserve lean muscle mass through structured resistance training guidance. Given that approximately 40% of weight lost on GLP-1 medications can come from lean mass without interventions, this is a genuinely useful addition.

Clinical Process: Video Consultations and Lab Testing

Noom Med stands out from Hims and Ro in offering video consultations as part of the enrollment and ongoing care process. This is not universal — some plans use async intake with a video follow-up if needed — but the availability of video clinical visits is a meaningful differentiator for patients who want to speak with their prescribing clinician.

Lab testing is ordered through Quest Diagnostics or LabCorp and is included in the cost of the program when clinically appropriate. In NY, NJ, and RI, insurance is required for lab coverage and extra costs may apply.

After completing labs, a licensed clinician reviews your health history, lab results, and goals to determine the appropriate treatment plan. This is a more comprehensive intake process than the questionnaire-only approach at Hims and more similar to Calibrate or Form Health in clinical rigor.

FDA-Approved Medication Access at Noom

For patients specifically seeking FDA-approved brand-name GLP-1 medications, the relevant Noom path is the Telehealth Plan at $69/month.

*Off-label prescribing for weight loss at clinician discretion.

Cash-pay pricing for brand-name medications through Noom's telehealth plan: Noom routes brand-name prescriptions to your preferred pharmacy or coordinates NovoCare/LillyDirect pricing. Medication costs are separate from the $69/month platform fee and priced at the same NovoCare and LillyDirect rates available through other platforms.

One area where Noom's brand-name cash pricing has been flagged as uncompetitive: third-party reviewers have noted that Noom's list pricing for Ozempic (~$1,000/month) and Mounjaro (~$1,200/month) is at retail pharmacy rates rather than manufacturer self-pay program rates. Confirm the specific cash-pay price for your medication before enrolling on the brand-name track.

Pricing Comparison: Where Noom Fits

For insured patients using the Telehealth Plan:

For insured patients with good brand-name GLP-1 coverage, Noom's Telehealth Plan at $69/month is the lowest-cost path to a full GLP-1 program with premium behavioral coaching. It undercuts Ro and Hims on total cost while offering more coaching depth.

For self-pay patients seeking brand-name medications without insurance, the cost calculation is different: the $69/month platform fee stacks on top of NovoCare/LillyDirect medication pricing, putting total costs at $218–$418/month depending on medication and dose — competitive with but not cheaper than Ro or Hims.

The Microdose Program: A Genuine Innovation

Noom's Microdose GLP-1Rx deserves specific attention because nothing quite like it exists at other major platforms.

The program caps semaglutide dosing at 0.25–0.6 mg — the starting range of the standard titration schedule — rather than titrating to the 2.4 mg therapeutic maintenance dose. The rationale:

• Many patients experience significant nausea, vomiting, and GI distress during GLP-1 dose escalation
• Some patients stop treatment entirely because of side effects at higher doses
• Lower doses still produce meaningful appetite suppression and metabolic effects for some patients, with substantially fewer side effects
• An entry point at lower doses allows patients to establish the habit of GLP-1 treatment and behavioral change before committing to the full-dose experience

At $99/month all-inclusive (medication, clinical oversight, coaching), the Microdose program is also one of the more accessible entry points in the market — though it uses compounded semaglutide, not FDA-approved Wegovy.

For patients who have tried and abandoned GLP-1 treatment because of side effects, or who are highly anxious about injections and nausea, the Microdose program offers a genuine alternative to either white-knuckling through a standard titration or giving up on medication altogether.

Insurance Navigation at Noom

Noom accepts insurance for brand-name medications on the Telehealth Plan. The process:

1. After enrollment, Noom's care team helps verify your insurance benefits
2. If your plan covers a GLP-1, your prescription is routed to a pharmacy for insurance billing
3. Manufacturer savings cards (Novo Nordisk, Eli Lilly) can reduce your copay to $0–$25/month if you have qualifying commercial insurance

Noom does not have the dedicated prior authorization concierge team that Ro has built. Insurance navigation support is available, but if your insurer requires a complex prior authorization, Ro is a materially better choice for managing that process.

Compounded medication plans at Noom are cash-pay only — no insurance accepted.

User Experience and Reviews

Noom's patient reviews are broadly positive on coaching quality and mixed on operational experience. Consistent themes across third-party platforms:

Praised consistently:

• The behavioral coaching curriculum is described as genuinely valuable and distinct from anything available elsewhere
• Human coach relationships are noted as responsive and personalized
• The Noom app is described as well-designed and easy to integrate into daily routine
• Video consultations appreciated vs. async-only alternatives

Recurring complaints:

• Cancellation process is consistently described as difficult — multiple reports of charges after cancellation attempts, requiring persistence to resolve. This is Noom's most significant operational weakness based on user feedback volume.
• The pricing structure is confusing: some users report not understanding which plan they enrolled in or that medication costs were separate from the quoted price
• Cash-pay brand-name pricing for some medications (particularly Ozempic, Mounjaro) quoted at retail rates rather than manufacturer self-pay rates
• Compounded medication availability in some states is limited post-FDA shortage resolution

The cancellation complaint is worth taking seriously. If you enroll, document your cancellation request and confirm it in writing. Noom's response to these complaints has been inconsistent based on available public record.

Who Noom Is Right For

Noom is the clear choice if:

• Behavioral coaching and habit change are a priority alongside medication
• You have commercial insurance that covers brand-name GLP-1s and want the lowest-cost full program ($69/month Telehealth Plan)
• You've tried GLP-1 medications before and stopped due to side effects — the Microdose program offers a gentler re-entry
• You want a video consultation with your prescribing clinician rather than async-only
• You want access to non-GLP-1 prescription options (metformin, Contrave) as part of the same platform

Noom may not be the right fit if:

• You want fast, frictionless access to brand-name medication — Hims or Sesame get you there faster
• Your insurer requires complex prior authorization — Ro's dedicated concierge is better equipped
• You are self-pay and want the lowest all-in cost for brand-name GLP-1s — Sesame or the annual Ro plan are more competitive
• You want to avoid compounded medications entirely and need clarity on which plan delivers brand-name — the Telehealth Plan at $69/month is the answer, but it requires navigating to it deliberately

How Noom Compares to Key Alternatives

Noom vs. Ro Body Program

For insured patients on the Telehealth Plan, Noom is significantly cheaper ($69/month vs. $149/month) and has better coaching. Ro has a stronger prior authorization concierge. For straightforward insurance coverage cases, Noom is the better value. For complex PA situations or patients who want managed insurance navigation, Ro is better.

Noom vs. Hims / Hers

Noom is cheaper on the Telehealth Plan, offers more clinical depth (video consultations, labs, human coach), and provides superior behavioral support. Hims is faster for first-dose access and offers the broadest medication menu including Wegovy HD. For most patients who are not specifically prioritizing speed, Noom's Telehealth Plan is a better overall value than Hims' base offering.

Noom vs. WeightWatchers Clinic

Both combine a lifestyle program with GLP-1 prescribing. WeightWatchers has a 60+ year brand and community; Noom has 15 years of CBT-based behavioral research. WeightWatchers starts at $99/month, Noom at $69/month for the Telehealth Plan. The programs appeal to different personalities: WW's Points system and community group model versus Noom's individualized CBT and 1-on-1 coach model.

Noom vs. Calibrate

Calibrate's one-year structured metabolic health program with in-network insurance billing is the most comprehensive option in the market for eligible insured patients. Noom is more accessible and flexible. For patients with qualifying insurance and a willingness to commit to a year-long program, Calibrate offers more intensive clinical oversight. For patients who want flexibility, Noom is easier to enter and exit.

Our Verdict

WeightRx Guide Rating: 4.1 / 5

Noom Med earns its rating through the strongest behavioral coaching program in GLP-1 telehealth — a perfect 5.0 on that dimension — and genuinely competitive pricing on the Telehealth Plan for insured patients.

The platform's complexity is both its strength and its weakness. The five-tier structure creates options for almost every patient profile, but it also creates real confusion that causes patients to enroll in the wrong plan, pay more than necessary, or misunderstand what they are getting. The advertising of low compounded prices alongside a separate brand-name track requires careful reading.

For insured patients who will use the behavioral coaching, Noom's Telehealth Plan at $69/month is one of the best values in the market. For patients who want the microdose entry point, the program is genuinely unique. For patients who want the fastest access to brand-name medication or the strongest prior auth support, Ro or Hims are better first choices.

Noom's cancellation issue is a real pattern that warrants caution. Go in knowing that exit may require persistence.

Frequently Asked Questions

Which Noom plan should I choose for FDA-approved brand-name GLP-1 medications?

The Telehealth Plan at $69/month is the right choice for patients seeking FDA-approved brand-name medications (Wegovy, Zepbound, Foundayo). This plan includes a clinical evaluation, prescription routing to a pharmacy, and full access to Noom's behavioral coaching platform. Medication costs are separate and depend on insurance coverage or cash-pay rates.

Does Noom accept insurance?

Yes — for brand-name medications on the Telehealth Plan. Noom's care team helps verify your insurance benefits and coordinates prescription routing for coverage. The structured compounded medication programs (Microdose, Full-Dose) are cash-pay only. The $69/month membership itself is always cash-pay.

What is the Microdose program and is it FDA-approved?

The Noom Microdose GLP-1Rx program ($99/month) uses compounded semaglutide capped at low doses (0.25–0.6 mg). Compounded semaglutide is not an FDA-approved medication — it is prepared by licensed 503B compounding pharmacies. The program is designed for patients who want to start at lower doses to manage side effects. The FDA-approved equivalent would be the starting doses of brand-name Wegovy on the Telehealth Plan.

Does Noom offer video consultations?

Yes — Noom Med includes video consultations as part of its clinical process, unlike Hims and Ro which use async-only consultation models. This is a meaningful differentiator for patients who prefer speaking with their prescribing clinician.

Is Noom available in all states?

The brand-name Telehealth Plan is available broadly. The compounded medication programs have limitations: they are unavailable or restricted in Alabama, Louisiana, and Mississippi. Telehealth medication access also has limitations in Virginia.

How hard is it to cancel Noom?

Cancellation has been a consistent pain point based on user reviews. To cancel, initiate through the app or by contacting support, document your request in writing (email to noommed@noom.com), and confirm receipt of your cancellation. Monitor your next billing cycle to verify no additional charges. If you are billed after cancellation, Noom's billing support line is (888) 266-5071.

What is Noom Weight vs. Noom Med?

Noom Weight is Noom's original app-only weight loss program — behavioral coaching, food tracking, and daily lessons without prescription medications. Noom Med adds clinical evaluation and prescription access. If you are seeking GLP-1 medications, Noom Med is the relevant product. Noom Weight is appropriate for patients not seeking prescription treatment.